S&P 500   3,258.96 (+0.38%)
DOW   26,848.56 (+0.12%)
QQQ   268.72 (+1.25%)
AAPL   110.57 (+2.17%)
MSFT   206.36 (+1.56%)
FB   251.04 (+0.61%)
GOOGL   1,427.77 (+0.35%)
AMZN   3,048.00 (+0.93%)
TSLA   406.88 (+4.92%)
NVDA   505.05 (+2.25%)
BABA   267.54 (-0.81%)
CGC   13.94 (-2.31%)
GE   6.05 (-0.17%)
MU   48.48 (-2.00%)
AMD   76.67 (+1.12%)
T   27.82 (-0.78%)
F   6.55 (-1.65%)
ACB   5.00 (-3.85%)
GILD   62.01 (-0.39%)
NFLX   477.38 (+0.91%)
DIS   122.69 (+0.16%)
BAC   23.22 (-0.51%)
BA   151.22 (+3.54%)
S&P 500   3,258.96 (+0.38%)
DOW   26,848.56 (+0.12%)
QQQ   268.72 (+1.25%)
AAPL   110.57 (+2.17%)
MSFT   206.36 (+1.56%)
FB   251.04 (+0.61%)
GOOGL   1,427.77 (+0.35%)
AMZN   3,048.00 (+0.93%)
TSLA   406.88 (+4.92%)
NVDA   505.05 (+2.25%)
BABA   267.54 (-0.81%)
CGC   13.94 (-2.31%)
GE   6.05 (-0.17%)
MU   48.48 (-2.00%)
AMD   76.67 (+1.12%)
T   27.82 (-0.78%)
F   6.55 (-1.65%)
ACB   5.00 (-3.85%)
GILD   62.01 (-0.39%)
NFLX   477.38 (+0.91%)
DIS   122.69 (+0.16%)
BAC   23.22 (-0.51%)
BA   151.22 (+3.54%)
S&P 500   3,258.96 (+0.38%)
DOW   26,848.56 (+0.12%)
QQQ   268.72 (+1.25%)
AAPL   110.57 (+2.17%)
MSFT   206.36 (+1.56%)
FB   251.04 (+0.61%)
GOOGL   1,427.77 (+0.35%)
AMZN   3,048.00 (+0.93%)
TSLA   406.88 (+4.92%)
NVDA   505.05 (+2.25%)
BABA   267.54 (-0.81%)
CGC   13.94 (-2.31%)
GE   6.05 (-0.17%)
MU   48.48 (-2.00%)
AMD   76.67 (+1.12%)
T   27.82 (-0.78%)
F   6.55 (-1.65%)
ACB   5.00 (-3.85%)
GILD   62.01 (-0.39%)
NFLX   477.38 (+0.91%)
DIS   122.69 (+0.16%)
BAC   23.22 (-0.51%)
BA   151.22 (+3.54%)
S&P 500   3,258.96 (+0.38%)
DOW   26,848.56 (+0.12%)
QQQ   268.72 (+1.25%)
AAPL   110.57 (+2.17%)
MSFT   206.36 (+1.56%)
FB   251.04 (+0.61%)
GOOGL   1,427.77 (+0.35%)
AMZN   3,048.00 (+0.93%)
TSLA   406.88 (+4.92%)
NVDA   505.05 (+2.25%)
BABA   267.54 (-0.81%)
CGC   13.94 (-2.31%)
GE   6.05 (-0.17%)
MU   48.48 (-2.00%)
AMD   76.67 (+1.12%)
T   27.82 (-0.78%)
F   6.55 (-1.65%)
ACB   5.00 (-3.85%)
GILD   62.01 (-0.39%)
NFLX   477.38 (+0.91%)
DIS   122.69 (+0.16%)
BAC   23.22 (-0.51%)
BA   151.22 (+3.54%)
Log in
NASDAQ:VERX

Repare Therapeutics Stock Forecast, Price & News

$22.30
+0.59 (+2.72 %)
(As of 09/25/2020 11:32 AM ET)
Add
Compare
Today's Range
$21.75
Now: $22.30
$22.45
50-Day Range
$21.85
MA: $24.67
$29.10
52-Week Range
$21.11
Now: $22.30
$29.69
Volume5,699 shs
Average Volume570,794 shs
Market Capitalization$3.19 billion
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Vertex, Inc. provides tax technology solutions for corporations in retail, leasing, communication, and manufacturing industries in the United States and internationally. It offers tax determination, compliance and reporting, tax data management, document management, pre-built integration, and industry-specific solutions. The company sells its software products through software license and software as a service subscriptions. It also offers implementation and training services in connection with its software license and cloud subscriptions, transaction tax returns outsourcing, and other tax-related services. The company was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 4.2Community Rank: 2.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.37 out of 5 stars


Industry, Sector and Symbol

Industry Prepackaged software
Sub-IndustryN/A
Current SymbolNASDAQ:VERX
CUSIPN/A
CIKN/A
Phone800-355-3500

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees1,100
Market Cap$3.19 billion
Next Earnings Date12/9/2020 (Estimated)
OptionableNot Optionable
$22.30
+0.59 (+2.72 %)
(As of 09/25/2020 11:32 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive VERX News and Ratings via Email

Sign-up to receive the latest news and ratings for VERX and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Repare Therapeutics (NASDAQ:VERX) Frequently Asked Questions

Do Wall Street analysts recommend investors buy shares of Repare Therapeutics?

9 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Repare Therapeutics in the last year. There are currently 5 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Hold."
View analyst ratings for Repare Therapeutics
.

When is Repare Therapeutics' next earnings date?

Repare Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, December 9th 2020.
View our earnings forecast for Repare Therapeutics
.

How were Repare Therapeutics' earnings last quarter?

Repare Therapeutics Inc. (NASDAQ:VERX) released its quarterly earnings results on Wednesday, September, 9th. The company reported ($0.18) earnings per share for the quarter, beating analysts' consensus estimates of ($0.24) by $0.06. The business earned $91.27 million during the quarter, compared to analyst estimates of $89.22 million.
View Repare Therapeutics' earnings history
.

What guidance has Repare Therapeutics issued on next quarter's earnings?

Repare Therapeutics issued an update on its third quarter 2020 Pre-Market earnings guidance on Wednesday, September, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $89-91 million, compared to the consensus revenue estimate of $89.44 million.

What price target have analysts set for VERX?

9 analysts have issued 1-year target prices for Repare Therapeutics' stock. Their forecasts range from $23.00 to $34.00. On average, they expect Repare Therapeutics' share price to reach $29.63 in the next twelve months. This suggests a possible upside of 32.8% from the stock's current price.
View analysts' price targets for Repare Therapeutics
.

Who are some of Repare Therapeutics' key competitors?

What other stocks do shareholders of Repare Therapeutics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Repare Therapeutics investors own include Carnival (CCL), Argan (AGX), Applied Genetic Technologies (AGTC), American Eagle Outfitters (AEO), Aehr Test Systems (AEHR), Advaxis (ADXS), ADT (ADT), Adobe (ADBE), Accenture (ACN) and Aurora Cannabis (ACB).

Who are Repare Therapeutics' key executives?

Repare Therapeutics' management team includes the following people:
  • Mr. David DeStefano, CEO, Pres & Chairman (Age 57, Pay $1.42M)
  • Ms. Lisa Butler, Chief Accounting Officer (Age 54, Pay $561.63k)
  • Mr. Bryan T. R. Rowland, Gen. Counsel & VP (Age 40, Pay $407.95k)
  • Mr. Jeffrey R. Westphal, Co-Owner & Director (Age 58)
  • Mr. Ray Westphal, Founder

When did Repare Therapeutics IPO?

(VERX) raised $318 million in an IPO on Wednesday, July 29th 2020. The company issued 21,200,000 shares at a price of $14.00-$16.00 per share. Goldman Sachs and Morgan Stanley acted as the underwriters for the IPO and BofA Securities, Citigroup, Jefferies, JMP Securities, Stifel, William Blair and CastleOak Securities were co-managers.

What is Repare Therapeutics' stock symbol?

Repare Therapeutics trades on the NASDAQ under the ticker symbol "VERX."

When did Repare Therapeutics' quiet period expire?

Repare Therapeutics' quiet period expired on Monday, September 7th. Repare Therapeutics had issued 21,150,000 shares in its initial public offering on July 29th. The total size of the offering was $401,850,000 based on an initial share price of $19.00. During Repare Therapeutics' quiet period, underwriters and any insiders involved in the IPO were prevented from issuing any earnings forecasts or research reports for the company because of regulations issued by the Securities and Exchange Commission. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Repare Therapeutics?

Shares of VERX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Repare Therapeutics' stock price today?

One share of VERX stock can currently be purchased for approximately $22.30.

How big of a company is Repare Therapeutics?

Repare Therapeutics has a market capitalization of $3.19 billion. Repare Therapeutics employs 1,100 workers across the globe.

What is Repare Therapeutics' official website?

The official website for Repare Therapeutics is www.vertexinc.com.

How can I contact Repare Therapeutics?

Repare Therapeutics' mailing address is 2301 RENAISSANCE BOULEVARD, KING OF PRUSSIA PA, 19406. The company can be reached via phone at 800-355-3500 or via email at [email protected]

This page was last updated on 9/25/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.